Work

Trastuzumab-Deruxtecan: Redefining HER2 as a Tumor Agnostic Biomarker

Year: 2024

Type: review

Source: Targeted Oncology

DOI: 10.1007/s11523-024-01079-4

Authors: Joseph Zouein, Elias Karam, John H. Strickler, Hampig Raphael Kourie

Institutions: Saint Joseph University, Duke Medical Center, Institut Gustave Roussy

Language: English

Topic: HER2/EGFR in Cancer Research

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4400332755

FWCI: 0.663

Cites: 38

Cited by: 13

Related to: 10